1. Home
  2. BGLC vs EZRA Comparison

BGLC vs EZRA Comparison

Compare BGLC & EZRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

N/A

Current Price

$2.09

Market Cap

5.0M

Sector

Health Care

ML Signal

N/A

Logo Reliance Global Group Inc. Common Stock

EZRA

Reliance Global Group Inc. Common Stock

N/A

Current Price

$3.89

Market Cap

4.1M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
BGLC
EZRA
Founded
2017
2013
Country
Malaysia
United States
Employees
N/A
40
Industry
Medical Specialities
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
5.0M
4.1M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
BGLC
EZRA
Price
$2.09
$3.89
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.0K
1.3M
Earning Date
04-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
N/A
EPS
N/A
N/A
Revenue
$7,424,911.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.92
$0.11
52 Week High
$15.19
$5.16

Technical Indicators

Market Signals
Indicator
BGLC
EZRA
Relative Strength Index (RSI) 47.20 84.38
Support Level $1.92 $0.17
Resistance Level $2.15 N/A
Average True Range (ATR) 0.07 0.14
MACD 0.02 0.45
Stochastic Oscillator 70.00 75.22

Price Performance

Historical Comparison
BGLC
EZRA

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is a Wyoming corporation with two principal operating subsidiaries in Malaysia: Chemrex Corporation Sdn. Bhd. (Chemrex) and MRNA Scientific Sdn. Bhd. (MRNA Scientific). Chemrex is engaged in the distribution of chemical raw materials, mainly for industrial applications in Southeast Asia. MRNA Scientific is engaged in the development and provision of blood-based genomic screening services intended to support early disease risk assessment and health management. Trading of industrial chemicals- Includes trading of industrial chemicals. Provision for genomic screening services- includes in commercializing proprietary blood-based diagnostic test for early disease detection. Investment holding- Investment holding, are its segments.

About EZRA Reliance Global Group Inc. Common Stock

Reliance Global Group Inc operates as a holding company that acquires, owns, and actively manages insurance and technology-focused businesses. The company focuses on growing by pursuing acquisition strategies initially, and focuses on wholesale and retail insurance agencies. Its primary move is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations. The Company operates as a single operating segment, the Insurance Segment, earning its revenues from insurance commissions.

Share on Social Networks: